BRIDGET MATIENZO: Open Payments
NPI 1619626926 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,099 in 43 payments from 14 companies in 2025. Trend: 2023 $697 · 2024 $1,190 · 2025 $1,099
Food & beverage: $1,099
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $296 |
| ABBVIE INC. | 9 | $214 |
| UCB, Inc. | 3 | $73 |
| Incyte Corporation | 3 | $71 |
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| Arcutis Biotherapeutics, Inc. | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
| Janssen Biotech, Inc. | 2 | $48 |
| Organon LLC | 2 | $45 |
Products named: DUPIXENT, SKYRIZI, SPEVIGO, Bimzelx, OPZELURA, Zoryve, TREMFYA, CIBINQO.
Industry payments across FL — which companies pay providers there.
